129 related articles for article (PubMed ID: 8021)
1. Hypotensive action of propranolol and a new beta-blocking agent, D-32 in conscious normotensive and renal hypertensive dogs.
Himori N; Izumi A; Hiramatsu Y
Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):4-18. PubMed ID: 8021
[TBL] [Abstract][Full Text] [Related]
2. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
Himori N; Ishimori T; Izumi A; Hiramatsu Y
Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effect of Niludipine (Bay a 7168) on conscious renal-hypertensive dogs.
Hiwatari M; Taira N
Arzneimittelforschung; 1979; 29(9):1373-6. PubMed ID: 583244
[TBL] [Abstract][Full Text] [Related]
4. [Antihypertensive effect of arotinolol (S-596), a new adrenergic beta blocking agent, on experimental hypertension].
Hara Y; Nakahara H; Miyagishi A; Nakatani H
Nihon Yakurigaku Zasshi; 1983 Aug; 82(2):103-16. PubMed ID: 6198264
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effects of the new calcium antagonist benidipine hydrochloride in conscious, renal-hypertensive dogs.
Karasawa A; Ikeda J; Yamada K; Kubo K; Oka T; Nakamizo N
Arzneimittelforschung; 1988 Nov; 38(11A):1695-7. PubMed ID: 3219142
[TBL] [Abstract][Full Text] [Related]
6. A further study on antihypertensive action of beta-adrenoceptor blocking agents in conscious, renal hypertensive dogs.
Himori N; Ishimori T; Taira N
Arch Int Pharmacodyn Ther; 1979 Nov; 242(1):115-27. PubMed ID: 44454
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological studies of N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride (MDL-899), a new long-acting antihypertensive vasodilator.
Baldoli E; Bianchi G; Corsico N; Di Francesco GF
Arzneimittelforschung; 1985; 35(5):818-26. PubMed ID: 2862874
[TBL] [Abstract][Full Text] [Related]
8. Acute cardiovascular activity of beta-adrenoceptor blocking drugs in awake or anaesthetized normotensive and hypertensive rats.
Davy M; Midol-Monnet M; Cohen Y; Wepierre J
Arch Int Pharmacodyn Ther; 1977 Dec; 230(2):257-78. PubMed ID: 603320
[TBL] [Abstract][Full Text] [Related]
9. Hypotensive action of OPC-1427, a new beta-adrenergic blocking agent in rats.
Sugawara K; Takami N; Ozaki M
Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):294-304. PubMed ID: 41497
[TBL] [Abstract][Full Text] [Related]
10. Extremely long-acting antihypertensive effects of KF-4317, a alpha- and beta 1-adrenoceptor blocker.
Kubo K; Ikeda J; Nakamura J; Nakamizo N
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):140-60. PubMed ID: 2865934
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacological properties of dl-2-(3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2'-thienyl) thiazole hydrochloride (S-596), a new beta-adrenergic blocking agent (author's transl)].
Hara Y; Sato E; Miyagishi A; Aono S; Nakatani H
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):707-20. PubMed ID: 94296
[TBL] [Abstract][Full Text] [Related]
12. [Effect of acebutolol, a cardioselective beta-adrenoceptor blocking agent, on the blood pressure in rats (author's transl)].
Takami N; Sugawara K; Ozaki M
Nihon Yakurigaku Zasshi; 1979 Oct; 75(7):747-54. PubMed ID: 44260
[TBL] [Abstract][Full Text] [Related]
13. Effect of intracisternal butoxamine, a beta-2 adrenoceptor blocking agent, on blood pressure and heart rate in the dog.
Montastruc JL; Montastruc P
Arch Int Pharmacodyn Ther; 1980 Jan; 243(1):132-8. PubMed ID: 7387255
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of bucindolol (MJ 13105) in conscious dogs.
Deitchman D; Byrne JE; Snyder RW
Arch Int Pharmacodyn Ther; 1980 Sep; 247(1):76-88. PubMed ID: 6108746
[TBL] [Abstract][Full Text] [Related]
15. Regional hemodynamic effects of the beta-adrenoceptor blockers tertatolol and propranolol in conscious spontaneously hypertensive rats.
Nievelstein HM; Tijssen CM; Smits JF; Struyker-Boudier HA
Arch Int Pharmacodyn Ther; 1986 Jul; 282(1):118-29. PubMed ID: 2876684
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
[TBL] [Abstract][Full Text] [Related]
17. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
Narita H; Murata S; Yabana H; Kikkawa K; Sugawara Y; Akimoto Y; Nagao T
Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
[TBL] [Abstract][Full Text] [Related]
18. Comparative antihypertensive effects of propranolol and metoprolol in DOC-treated rats.
Wendt RL; Much DR; Bergey JL; Wicks TC
Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):110-20. PubMed ID: 7325751
[TBL] [Abstract][Full Text] [Related]
19. Effects of arotinolol on hemodynamics and adrenergically induced renin release and renal vasoconstriction.
Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
Arzneimittelforschung; 1988 May; 38(5):671-7. PubMed ID: 2458109
[TBL] [Abstract][Full Text] [Related]
20. SD-3211, a novel benzothiazine calcium antagonist, alone and in combination with a beta-adrenoceptor antagonist, produces antihypertensive effects without affecting heart rate and atrioventricular conduction in conscious renal hypertensive dogs.
Kageyama M; Nishimura K; Takada T; Miyawaki N; Yamauchi H
J Cardiovasc Pharmacol; 1991 Jan; 17(1):102-7. PubMed ID: 1708042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
